New drug shrinks tumors in Hard-to-Treat bladder cancer
Disease control
Completed
This study tested enfortumab vedotin, a drug that delivers chemotherapy directly to cancer cells, in 40 Chinese patients with advanced bladder cancer that had worsened after standard treatments. The main goal was to see how many patients' tumors shrank. The trial also looked at h…
Phase: PHASE2 • Sponsor: Astellas Pharma China, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC